Skip to main content
Log in

Failure to confirm benefit of acetyl-dl-leucine in degenerative cerebellar ataxia: a case series

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP et al (2013) Effects of acetyl-dl-leucine in patients with cerebellar ataxia: a case series. J Neurol 260:2556–2561

    Article  PubMed Central  PubMed  Google Scholar 

  2. Ilg W, Synofzik M, Brotz D, Burkard S, Giese MA, Schöls L (2009) Intensive coordinative training improves motor performance in degenerative cerebellar disease. Neurology 73:1823–1830

    Article  CAS  PubMed  Google Scholar 

  3. Miyai I, Ito M, Hattori N, Mihara M, Hatakenaka M, Yagura H et al (2012) Cerebellar ataxia rehabilitation trial in degenerative cerebellar diseases. Neurorehabil Neural Repair 26:515–522

    Article  PubMed  Google Scholar 

  4. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Schmitz-Hübsch T, Du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66:1717–1720

    Article  PubMed  Google Scholar 

  6. Weyer A, Abele M, Schmitz-Hübsch T, Schoch B, Frings M, Timmann D et al (2007) Reliability and validity of the scale for the assessment and rating of ataxia: a study in 64 ataxia patients. Mov Disord 22:1633–1637

    Article  PubMed  Google Scholar 

  7. Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I et al (2013) Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ 185:E201–E211

    Article  PubMed Central  PubMed  Google Scholar 

  8. Vibert N, Vidal PP (2001) In vitro effects of acetyl-dl-leucine (tanganil) on central vestibular neurons and vestibulo-ocular networks of the guinea-pig. Eur J Neurosci 13:735–748

    Article  CAS  PubMed  Google Scholar 

  9. Ferber-Viart C, Dubreuil C, Vidal PP (2009) Effects of acetyl-dl-leucine in vestibular patients: a clinical study following neurotomy and labyrinthectomy. Audiol Neurotol 14:17–25

    Article  CAS  Google Scholar 

Download references

Acknowledgments

No funding was received for this work.

Conflicts of interest

The authors declare that there are no conflicts of interest relevant to this work.

Ethical standard

The authors declare that the research documented has been carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph Classen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pelz, J.O., Fricke, C., Saur, D. et al. Failure to confirm benefit of acetyl-dl-leucine in degenerative cerebellar ataxia: a case series. J Neurol 262, 1373–1375 (2015). https://doi.org/10.1007/s00415-015-7734-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-015-7734-3

Keywords

Navigation